相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nonclinical Evaluation of Antibacterial Oxazolidinones Contezolid and Contezolid Acefosamil with Low Serotonergic Neurotoxicity
Wen Wang et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2021)
Emerging Treatment Options for Infections by Multidrug-Resistant Gram-Positive Microorganisms
Despoina Koulenti et al.
MICROORGANISMS (2020)
Population Pharmacokinetics Study of Contezolid (MRX-I), a Novel Oxazolidinone Antibacterial Agent, in Chinese Patients
Li Li et al.
CLINICAL THERAPEUTICS (2020)
In Vitro Activity and Potency of the Novel Oxazolidinone Contezolid (MRX-I) Tested against Gram-Positive Clinical Isolates from the United States and Europe
Cecilia G. Carvalhaes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
In vitro and in vivo activity of contezolid (MRX-I) against Mycobacterium tuberculosis
Carolyn Shoen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Short-term Safety, Tolerability, and Pharmacokinetics of MRX-I, an Oxazolidinone Antibacterial Agent, in Healthy Chinese Subjects
Xiaojie Wu et al.
CLINICAL THERAPEUTICS (2018)
Metabolism of MRX-I, a Novel Antibacterial Oxazolidinone, in Humans: The Oxidative Ring Opening of 2,3-Dihydropyridin-4-One Catalyzed by Non-P450 Enzymes
Jian Meng et al.
DRUG METABOLISM AND DISPOSITION (2015)
In Vivo Antibacterial Activity of MRX-I, a New Oxazolidinone
Cong-Ran Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
分享论文
